Pharmacyclics competitorsClear all

Pharmacyclics's top competitors include CytomX Therapeutics, AVEO Pharmaceuticals, Merrimack Pharmaceuticals and Clovis Oncology.
Pharmacyclics
Pharmacyclics
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
AVEO Pharmaceuticals
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Clovis Oncology
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Founding Date
Founding Date
1991
Founding Date
2008
Founding Date
2001
Founding Date
2000
Founding Date
2009
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Sunnyvale, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Boulder, US HQ
Employees
Employees
N/A
Employees
13749% increase
Employees
1711% decrease
Employees
2763% decrease
Employees
46830% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
466.7 m
Valuation ($)
115.5 m
Valuation ($)
76.9 m
Valuation ($)
730.9 m
Twitter followers
Twitter followers
1 k
Twitter followers
677
Twitter followers
829
Twitter followers
1.1 k
Twitter followers
647
Number of tweets (last 30 days)
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.9
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
558442
Alexa Website Rank
995240
Alexa Website Rank
748297
Alexa Website Rank
400267
Alexa Website Rank
217363

Financial

Revenue (est.)
Revenue (est.)
$729.7m (FY, 2014)
Revenue (est.)
$59.5m (FY, 2018)
Revenue (est.)
$5.4m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
$86.1m (FY, 2014)
Net income
($84.6m) (FY, 2018)
Net income
($5.3m) (FY, 2018)
Net income
($40.5m) (FY, 2018)
Net income
($368m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 132.4m
Total funding raised
$ 224m
Total funding raised
$ 79.4m
Total funding raised
$ 357m
For sources of this data, please see the company profile

View company profiles

CytomX Therapeutics
HQ
South San Francisco, US
Employees
137↑ 49% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
17↓ 11% decrease

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
Clovis Oncology
HQ
Boulder, US
Employees
468↑ 30% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company